🇺🇸 FDA
Pipeline program

PEGINTERFERON ALFA-2A , TIL cells, Zirconium Zr 89 crefmirlimab berdoxam

Phase 2 small_molecule active

Quick answer

PEGINTERFERON ALFA-2A , TIL cells, Zirconium Zr 89 crefmirlimab berdoxam for Metastatic Melanoma is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Metastatic Melanoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials